AIRLINK 74.45 Increased By ▲ 0.16 (0.22%)
BOP 4.95 No Change ▼ 0.00 (0%)
CNERGY 4.35 Decreased By ▼ -0.02 (-0.46%)
DFML 39.35 Increased By ▲ 0.55 (1.42%)
DGKC 85.38 Increased By ▲ 0.56 (0.66%)
FCCL 21.32 Increased By ▲ 0.11 (0.52%)
FFBL 33.90 Decreased By ▼ -0.22 (-0.64%)
FFL 9.67 Decreased By ▼ -0.03 (-0.31%)
GGL 10.50 Increased By ▲ 0.08 (0.77%)
HBL 112.99 Decreased By ▼ -0.01 (-0.01%)
HUBC 137.00 Increased By ▲ 0.80 (0.59%)
HUMNL 12.00 Increased By ▲ 0.10 (0.84%)
KEL 4.72 Increased By ▲ 0.01 (0.21%)
KOSM 4.43 Decreased By ▼ -0.01 (-0.23%)
MLCF 37.94 Increased By ▲ 0.29 (0.77%)
OGDC 138.00 Increased By ▲ 1.80 (1.32%)
PAEL 25.25 Increased By ▲ 0.15 (0.6%)
PIAA 20.06 Increased By ▲ 0.82 (4.26%)
PIBTL 6.70 Decreased By ▼ -0.01 (-0.15%)
PPL 122.80 Increased By ▲ 0.70 (0.57%)
PRL 26.90 Increased By ▲ 0.25 (0.94%)
PTC 13.96 Increased By ▲ 0.03 (0.22%)
SEARL 57.80 Increased By ▲ 0.58 (1.01%)
SNGP 67.50 Decreased By ▼ -0.10 (-0.15%)
SSGC 10.32 Increased By ▲ 0.07 (0.68%)
TELE 8.42 Increased By ▲ 0.02 (0.24%)
TPLP 11.14 Increased By ▲ 0.01 (0.09%)
TRG 63.15 Increased By ▲ 0.34 (0.54%)
UNITY 26.55 Increased By ▲ 0.05 (0.19%)
WTL 1.41 Increased By ▲ 0.06 (4.44%)
BR100 7,819 Increased By 9.1 (0.12%)
BR30 25,295 Increased By 145 (0.58%)
KSE100 74,996 Increased By 39.6 (0.05%)
KSE30 24,101 Increased By 17.8 (0.07%)
Pakistan

SHC directs govt to fix price of COVID-19 vaccine

  • On March 18, the court had suspended the drug regulatory authority’s notification concerning the withdrawal of exemption in Covid-19 vaccines import to a private pharma company
  • DRAP counsel requested the court to not allow the sale of the vaccine until its price is fixed
Published March 31, 2021

(Karachi) The Sindh High Court (SHC) has directed the federal government to fix the price of the coronavirus vaccine imported by the private sector in a week, local media reported Wednesday.

As per details, a two-member bench comprising Justice Muhammad Ali Mazhar and Justice Amjad Ali Sahito disposed of an appeal of the Drug Regulatory Authority of Pakistan (DRAP) that challenged a single bench’s March 18 verdict.

On March 18, the court had suspended the drug regulatory authority’s notification concerning the withdrawal of exemption in Covid-19 vaccines import to a private pharma company.

The firm’s lawyer stated before the court that the DRAP allowed the import of vaccine under certain conditions on February 2, following which the pharma company imported one million doses of Russia’s Sputnik-V vaccine.

He lamented that the firm is not being allowed to sell the vaccine. “We have already invested $45 million and imported the vaccine. What should we do now?” he asked.

A DRAP counsel requested the court to not allow the sale of the vaccine until its price is fixed.

Comments

Comments are closed.